Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CXR-1002 shows promising safety and antitumor activity in first-in-human trial in advanced cancer

Nov. 30, 2010

New apoptosis-inducing molecules discovered

Nov. 30, 2010

Profectus BioSciences divulges new NF-kappa-B inhibitors

Nov. 29, 2010

New inhibitors of E-selectin and chemokine CXCR4 receptor claimed

Nov. 29, 2010

SAR-153192 suppresses tumor growth in vivo and continues evaluation in phase I trial

Nov. 29, 2010

New oxalato complexes of platinum disclosed for treatment of cancer

Nov. 26, 2010

First-in-human data presented on RO-5126766 in advanced/metastatic solid tumors

Nov. 26, 2010

Tragara advances multikinase inhibitor SB-1317 to phase I trial

Nov. 25, 2010

Boehringer Ingelheim patents novel PI3K inhibitors

Nov. 25, 2010

Roche claims new inhibitors of Mdm2-p53 interaction

Nov. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...